Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Motohiro Tamiya

Showing results (121-130 of 192) with videos related to

Pageof 20
Sort By:
BMC Cancer|October 19, 2014
Comparison of the clinical courses and chemotherapy outcomes in metastatic colorectal cancer patients with and without active Mycobacterium tuberculosis or Mycobacterium kansasii infection: a retrospective studyTomonori Hirashima, Takayuki Nagai, Hironori Shigeoka, et al.
Medicine|September 1, 2017
Efficacy of nanoparticle albumin-bound paclitaxel regimens for relapsed small cell lung cancer: A retrospective analysisYujiro Naito, Akihiro Tamiya, Motohiro Tamiya, et al.
European Journal of Cancer (Oxford, England : 1990)|March 11, 2023
Multicentre real-world data of ramucirumab plus docetaxel after combined platinum-based chemotherapy with programmed death-1 blockade in advanced non-small cell lung cancer: NEJ051 (REACTIVE study)Atsushi Nakamura, Ou Yamaguchi, Keita Mori, et al.
Scientific Reports|February 15, 2024
Prophylactic pegfilgrastim reduces febrile neutropenia in ramucirumab plus docetaxel after chemoimmunotherapy in advanced NSCLC: post hoc analysis from NEJ051Keita Miura, Ou Yamaguchi, Keita Mori, et al.
Anticancer Research|July 26, 2017
Cerebrospinal Fluid Penetration Rate and Efficacy of Afatinib in Patients with EGFR Mutation-positive Non-small Cell Lung Cancer with Leptomeningeal Carcinomatosis: A Multicenter Prospective StudyAkihiro Tamiya, Motohiro Tamiya, Takashi Nishihara, et al.
Future Oncology (London, England)|June 4, 2020
Improvement strategies for successful next-generation sequencing analysis of lung cancerKei Kunimasa, Shingo Matsumoto, Kazumi Nishino, et al.
Anticancer Research|July 31, 2020
A Multivariable Regression Model-based Nomogram for Estimating the Overall Survival of Patients Previously Treated With Nivolumab for Advanced Non-small-cell Lung CancerAkihiro Tamiya, Motohiro Tamiya, Hirofumi Go, et al.
Investigational New Drugs|February 5, 2021
Phase 2 study of bevacizumab plus carboplatin/nab-paclitaxel followed by bevacizumab plus nab-paclitaxel for non-squamous non-small cell lung cancer with malignant pleural effusionMotohiro Tamiya, Akihiro Tamiya, Hidekazu Suzuki, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 23, 2021
Intensity-modulated radiation therapy with concurrent chemotherapy followed by durvalumab for stage III non-small cell lung cancer: A multi-center retrospective studyYoko Tsukita, Takaya Yamamoto, Hiroshi Mayahara, et al.
Anticancer Research|July 31, 2012
Efficacy of carboplatin and paclitaxel with bevacizumab as salvage chemotherapy for non-small cell lung cancer after failure of platinum-doublet chemotherapyMotohiro Tamiya, Akihiro Tamiya, Keiko Nakao, et al.
Pageof 20

Showing results (121-130 of 192) with videos related to

Sort By:
Pageof 20
BMC Cancer|October 19, 2014
Comparison of the clinical courses and chemotherapy outcomes in metastatic colorectal cancer patients with and without active Mycobacterium tuberculosis or Mycobacterium kansasii infection: a retrospective studyTomonori Hirashima, Takayuki Nagai, Hironori Shigeoka, et al.
Medicine|September 1, 2017
Efficacy of nanoparticle albumin-bound paclitaxel regimens for relapsed small cell lung cancer: A retrospective analysisYujiro Naito, Akihiro Tamiya, Motohiro Tamiya, et al.
European Journal of Cancer (Oxford, England : 1990)|March 11, 2023
Multicentre real-world data of ramucirumab plus docetaxel after combined platinum-based chemotherapy with programmed death-1 blockade in advanced non-small cell lung cancer: NEJ051 (REACTIVE study)Atsushi Nakamura, Ou Yamaguchi, Keita Mori, et al.
Scientific Reports|February 15, 2024
Prophylactic pegfilgrastim reduces febrile neutropenia in ramucirumab plus docetaxel after chemoimmunotherapy in advanced NSCLC: post hoc analysis from NEJ051Keita Miura, Ou Yamaguchi, Keita Mori, et al.
Anticancer Research|July 26, 2017
Cerebrospinal Fluid Penetration Rate and Efficacy of Afatinib in Patients with EGFR Mutation-positive Non-small Cell Lung Cancer with Leptomeningeal Carcinomatosis: A Multicenter Prospective StudyAkihiro Tamiya, Motohiro Tamiya, Takashi Nishihara, et al.
Future Oncology (London, England)|June 4, 2020
Improvement strategies for successful next-generation sequencing analysis of lung cancerKei Kunimasa, Shingo Matsumoto, Kazumi Nishino, et al.
Anticancer Research|July 31, 2020
A Multivariable Regression Model-based Nomogram for Estimating the Overall Survival of Patients Previously Treated With Nivolumab for Advanced Non-small-cell Lung CancerAkihiro Tamiya, Motohiro Tamiya, Hirofumi Go, et al.
Investigational New Drugs|February 5, 2021
Phase 2 study of bevacizumab plus carboplatin/nab-paclitaxel followed by bevacizumab plus nab-paclitaxel for non-squamous non-small cell lung cancer with malignant pleural effusionMotohiro Tamiya, Akihiro Tamiya, Hidekazu Suzuki, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 23, 2021
Intensity-modulated radiation therapy with concurrent chemotherapy followed by durvalumab for stage III non-small cell lung cancer: A multi-center retrospective studyYoko Tsukita, Takaya Yamamoto, Hiroshi Mayahara, et al.
Anticancer Research|July 31, 2012
Efficacy of carboplatin and paclitaxel with bevacizumab as salvage chemotherapy for non-small cell lung cancer after failure of platinum-doublet chemotherapyMotohiro Tamiya, Akihiro Tamiya, Keiko Nakao, et al.
Pageof 20